ORIFARM A/S: Financial statements 2017
CVR: 26058708
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
ORIFARM A/S (CVR 26058708) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 1,192,494,000 and a net result of DKK 4,424,000 compared with DKK 3,640,000 the year before. That is a decrease of 0.8% compared with the year before. The profit margin was 0.4%. Equity in the 2017 report amounted to DKK 36,298,000. The solvency ratio was 15.6%. The company had 42 employees in the financial year.
- Revenue
- DKK 1,192,494,000
- Gross Profit
- DKK 34,473,000
- Profit/Loss
- DKK 4,424,000
- Equity
- DKK 36,298,000
- Total Assets
- DKK 232,008,000
- Employees
- 42
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 1.2 mia. | 34.5 mio. | 4.4 mio. | 36.3 mio. | 42 |
| 2016 | 1.2 mia. | 58 mio. | 3.6 mio. | 31.9 mio. | 72 |
| 2015 | 1 mia. | 52.2 mio. | 5.4 mio. | 28.2 mio. | - |
| 2014 | 1.1 mia. | 46.8 mio. | 4.4 mio. | 22.8 mio. | - |
| 2013 | 1.1 mia. | 42.2 mio. | 4.5 mio. | 18.4 mio. | - |
Official annual report
Keep an eye on ORIFARM A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
ORIFARM A/S has published its annual report for 2016. Revenue came to DKK 1,202,590,000, and the net result was DKK 3,640,000.
About ORIFARM A/S
ORIFARM A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JUT NR. 2181 A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM PI A/S. The company has 39 employees (2026). In 2025, the company reported revenue of DKK 1,174,659,000 and a net result of DKK 9,727,000 compared with DKK 14,865,000 the year before. Equity in the 2025 report amounted to DKK 44,048,000.